NYSEAMERICAN:YCBD cbdMD (YCBD) Stock Price, News & Analysis → (Free Workshop) Advanced “bug-out bag” hacks! (From Warrior Life) (Ad) Free YCBD Stock Alerts $0.65 +0.01 (+2.20%) (As of 06/14/2024 08:52 PM ET) Add Compare Share Share Today's Range$0.62▼$0.6650-Day Range N/A52-Week Range$0.56▼$2.19Volume64,400 shsAverage Volume236,790 shsMarket Capitalization$2.51 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Get cbdMD alerts: Email Address cbdMD MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside362.2% Upside$3.00 Price TargetShort InterestBearish5.51% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.98 out of 5 stars 3.5 Analyst's Opinion Consensus RatingcbdMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoveragecbdMD has received no research coverage in the past 90 days.Read more about cbdMD's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.51% of the float of cbdMD has been sold short.Short Interest Ratio / Days to CovercbdMD has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in cbdMD has recently increased by 3.80%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldcbdMD does not currently pay a dividend.Dividend GrowthcbdMD does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for YCBD. Previous Next N/A News and Social Media Coverage Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, cbdMD insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.95% of the stock of cbdMD is held by insiders.Percentage Held by InstitutionsOnly 7.18% of the stock of cbdMD is held by institutions.Read more about cbdMD's insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of cbdMD is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of cbdMD is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatiocbdMD has a P/B Ratio of 0.21. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Warrior Life(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” Most citizens don’t… but according to my friend (and best-selling survival author), Jeff, even the hardcore “preppers” who cherish their bug-out bags are doing it all wrong!All the details are right here… About cbdMD Stock (NYSEAMERICAN:YCBD)cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.Read More YCBD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart YCBD Stock News HeadlinesJune 5, 2024 | investorplace.comFarm Bill 2024: 3 Stocks That Would Get Smoked if Hemp Ban PassesMay 18, 2024 | markets.businessinsider.comAnalyst Maintains ‘Buy’ Rating for cbdMD Amidst Challenges, Citing Brand Strength and Strategic InitiativesMay 16, 2024 | finance.yahoo.comcbdMD Inc (YCBD) Q2 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...May 15, 2024 | msn.comcbdMD's Financial Results: Cost-Cutting Measures For Positive Cash Flow Amid Increasing LossesMay 15, 2024 | markets.businessinsider.comHere's what to expect from cbdMD's earningsApril 24, 2024 | forbes.comBest Lift Chairs For Seniors: A 2024 GuideMarch 23, 2024 | finance.yahoo.comcbdMD, Inc. (YCBD) Stock Historical Prices & Data - Yahoo FinanceFebruary 13, 2024 | finance.yahoo.comcbdMD Reduces Year over Year Net Loss from Operations by $3.0 MillionFebruary 8, 2024 | finance.yahoo.comcbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 ResultsFebruary 8, 2024 | finance.yahoo.comcbdMD Welcomes Vice President of Wholesale Sales, Joe Baghadjian- Paving the Way for Future GrowthFebruary 3, 2024 | msn.comcbdMD Secures $1.25M Through Convertible Note AgreementJanuary 31, 2024 | finance.yahoo.comcbdMD Unveils THCV+CBG Energy Softgels, Ushering in a New Era of Wellness SolutionsJanuary 18, 2024 | finance.yahoo.comcbdMD Launches into Sprouts Farmers Market, Bringing Premium CBD Gummies to 175 Stores NationwideJanuary 15, 2024 | benzinga.comcbdMD Stock (AMEX:YCBD), Guidance and ForecastDecember 30, 2023 | markets.businessinsider.comOptimistic Outlook: Buy Rating Affirmed for cbdMD Amid Growth Initiatives and Strategic ExpansionDecember 27, 2023 | msn.comYCBD Stock Earnings: cbdMD Reported Results for Q4 2023December 26, 2023 | benzinga.comCBD Giant's Challenging Year: Q4 Net Sales Slide By 27% But Net Loss Narrows 67% YoYDecember 22, 2023 | msn.comLaidlaw cuts Cingulate to hold, cites dwindling resourcesDecember 20, 2023 | finance.yahoo.comcbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 ResultsDecember 14, 2023 | finance.yahoo.comcbdMD Wins Awards in Two Categories at Prestigious Best in Biz AwardsNovember 15, 2023 | seekingalpha.comYCBD.PR.A cbdMD, Inc. 8% SER A CUM PFDOctober 25, 2023 | finance.yahoo.comcbdMD Announces Cancellation of Special MeetingOctober 6, 2023 | nasdaq.comMaxim Group Initiates Coverage of cbdMD (YCBD) with Buy RecommendationOctober 5, 2023 | benzinga.comCosta Rica's FIFA-Recognized Soccer Team Turns To CBD For Injury Prevention & HealingOctober 5, 2023 | finance.yahoo.comcbdMD Announces Historic Partnership with FIFA-Affiliated Costa Rican Soccer TeamSee More Headlines Receive YCBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for cbdMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today6/16/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorBusiness Services Industry Toilet preparations Sub-IndustryN/A Current SymbolNYSEAMERICAN:YCBD CUSIPN/A CIKN/A Webwww.cbdmd.com Phone(704) 445-3060FaxN/AEmployees52Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Potential Upside/Downside+362.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($12.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-22,940,000.00 Net Margins-102.25% Pretax Margin-102.25% Return on Equity-193.04% Return on Assets-109.90% Debt Debt-to-Equity Ratio0.88 Current Ratio1.07 Quick Ratio0.61 Sales & Book Value Annual Sales$24.16 million Price / Sales0.10 Cash FlowN/A Price / Cash FlowN/A Book Value$3.16 per share Price / Book0.21Miscellaneous Outstanding Shares3,870,000Free Float3,832,000Market Cap$2.51 million OptionableNot Optionable Beta1.99 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. T. Ronan Kennedy (Age 44)Interim CEO, CFO & Principal Executive Officer Comp: $275kDr. Sibyl Swift Ph.D. (Age 43)CSO, VP of Regulatory Affairs & Director Mr. Bradley Whitford (Age 43)Chief Accounting Officer, Treasurer & Secretary Zeb BookerChief Technology OfficerMr. John WestonDirector of Investor RelationsMr. Lance Blundell (Age 53)General Counsel Robert PettwayDirector of Public RelationsMr. Francisco Mangual (Age 45)Senior VP of Sales Ms. Shannon CharlesChief Marketing OfficerMr. David Johnson (Age 54)Senior VP of Business Development More ExecutivesKey CompetitorsStephanOTCMKTS:SPCOLee PharmaceuticalsOTCMKTS:LPHMGlobal Digital SolutionsOTCMKTS:GDSIAscendia BrandsOTCMKTS:ASCBQCCA IndustriesOTCMKTS:CAWWView All Competitors YCBD Stock Analysis - Frequently Asked Questions Should I buy or sell cbdMD stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for cbdMD in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" YCBD shares. View YCBD analyst ratings or view top-rated stocks. What is cbdMD's stock price target for 2024? 1 equities research analysts have issued 12 month target prices for cbdMD's shares. Their YCBD share price targets range from $3.00 to $3.00. On average, they predict the company's share price to reach $3.00 in the next twelve months. This suggests a possible upside of 362.2% from the stock's current price. View analysts price targets for YCBD or view top-rated stocks among Wall Street analysts. How were cbdMD's earnings last quarter? cbdMD, Inc. (NYSEAMERICAN:YCBD) issued its earnings results on Wednesday, May, 15th. The company reported ($1.35) earnings per share (EPS) for the quarter. The company had revenue of $4.82 million for the quarter. cbdMD had a negative trailing twelve-month return on equity of 193.04% and a negative net margin of 102.25%. What ETF holds cbdMD's stock? AXS Cannabis ETF holds 37,247 shares of YCBD stock, representing 0.35% of its portfolio. When did cbdMD's stock split? cbdMD's stock reverse split before market open on Tuesday, April 25th 2023. The 1-45 reverse split was announced on Tuesday, April 25th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. What other stocks do shareholders of cbdMD own? Based on aggregate information from My MarketBeat watchlists, some companies that other cbdMD investors own include KushCo (KSHB), ADMA Biologics (ADMA), Novan (NOVN), Bionano Genomics (BNGO), CNBX Pharmaceuticals (CNBX), Enerplus (ERF), Matinas BioPharma (MTNB), Organigram (OGI) and Pennsylvania Real Estate Investment Trust (PEI). How do I buy shares of cbdMD? Shares of YCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:YCBD) was last updated on 6/17/2024 by MarketBeat.com Staff From Our Partners(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredBitcoin’s Biggest Year Yet2024 is set to be a historic year for Bitcoin. It’s all thanks to three major catalysts that I reveal in my...Paradigm Press | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredTrump conviction scandal exposedIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the...Porter & Company | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding cbdMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share cbdMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.